Petkau TL, Leavitt BR (2014) Progranulin in neurodegenerative disease. Trends Neurosci 37(7):388–398. https://doi.org/10.1016/j.tins.2014.04.003

Article  CAS  PubMed  Google Scholar 

Bateman A, Cheung ST, Bennett HPJ (2018) A brief overview of progranulin in health and disease. Methods Mol Biol 1806:3–15. https://doi.org/10.1007/978-1-4939-8559-3_1

Article  CAS  PubMed  Google Scholar 

Cenik B, Sephton CF, Kutluk Cenik B, Herz J, Yu G (2012) Progranulin: a proteolytically processed protein at the crossroads of inflammation and neurodegeneration. J Biol Chem 287(39):32298–32306. https://doi.org/10.1074/jbc.R112.399170

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kao AW, McKay A, Singh PP, Brunet A, Huang EJ (2017) Progranulin, lysosomal regulation and neurodegenerative disease. Nat Rev Neurosci 18(6):325–333. https://doi.org/10.1038/nrn.2017.36

Article  CAS  PubMed  PubMed Central  Google Scholar 

Nguyen AD, Nguyen TA, Martens LH, Mitic LL, Farese RV Jr (2013) Progranulin: at the interface of neurodegenerative and metabolic diseases. Trends Endocrinol Metab 24(12):597–606. https://doi.org/10.1016/j.tem.2013.08.003

Article  CAS  PubMed  Google Scholar 

Baker M, Mackenzie IR, Pickering-Brown SM, Gass J, Rademakers R, Lindholm C, Snowden J, Adamson J et al (2006) Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17. Nature 442(7105):916–919. https://doi.org/10.1038/nature05016

Article  CAS  PubMed  Google Scholar 

Cruts M, Gijselinck I, van der Zee J, Engelborghs S, Wils H, Pirici D, Rademakers R, Vandenberghe R et al (2006) Null mutations in progranulin cause ubiquitin-positive frontotemporal dementia linked to chromosome 17q21. Nature 442(7105):920–924. https://doi.org/10.1038/nature05017

Article  CAS  PubMed  Google Scholar 

Gass J, Cannon A, Mackenzie IR, Boeve B, Baker M, Adamson J, Crook R, Melquist S et al (2006) Mutations in progranulin are a major cause of ubiquitin-positive frontotemporal lobar degeneration. Hum Mol Genet 15(20):2988–3001. https://doi.org/10.1093/hmg/ddl241

Article  CAS  PubMed  Google Scholar 

Miller B, Llibre Guerra JJ (2019) Frontotemporal dementia. Handb Clin Neurol 165:33–45. https://doi.org/10.1016/b978-0-444-64012-3.00003-4

Article  PubMed  Google Scholar 

Neumann M, Sampathu DM, Kwong LK, Truax AC, Micsenyi MC, Chou TT, Bruce J, Schuck T et al (2006) Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science 314(5796):130–133. https://doi.org/10.1126/science.1134108

Article  CAS  PubMed  Google Scholar 

Bevan-Jones WR, Cope TE, Jones PS, Kaalund SS, Passamonti L, Allinson K, Green O, Hong YT et al (2020) Neuroinflammation and protein aggregation co-localize across the frontotemporal dementia spectrum. Brain 143(3):1010–1026. https://doi.org/10.1093/brain/awaa033

Article  PubMed  PubMed Central  Google Scholar 

Rohrer JD, Woollacott IOC, Dick KM, Brotherhood E, Gordon E, Fellows A, Toombs J, Druyeh R et al (2016) Serum neurofilament light chain protein is a measure of disease intensity in frontotemporal dementia. Neurology 87(13):1329–1336

Article  CAS  PubMed  PubMed Central  Google Scholar 

Meeter LH, Dopper EG, Jiskoot LC, Sanchez-Valle R, Graff C, Benussi L, Ghidoni R, Pijnenburg YA et al (2016) Neurofilament light chain: a biomarker for genetic frontotemporal dementia. Ann Clin Transl Neurol 3(8):623–636. https://doi.org/10.1002/acn3.325

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhu N, Santos-Santos M, Illán-Gala I, Montal V, Estellés T, Barroeta I, Altuna M, Arranz J et al (2021) Plasma glial fibrillary acidic protein and neurofilament light chain for the diagnostic and prognostic evaluation of frontotemporal dementia. Transl Neurodegener 10(1):50. https://doi.org/10.1186/s40035-021-00275-w

Article  CAS  PubMed  PubMed Central  Google Scholar 

Suárez-Calvet M, Dols-Icardo O, Lladó A, Sánchez-Valle R, Hernández I, Amer G, Antón-Aguirre S, Alcolea D et al (2014) Plasma phosphorylated TDP-43 levels are elevated in patients with frontotemporal dementia carrying a C9orf72 repeat expansion or a GRN mutation. J Neurol Neurosurg Psychiatry 85(6):684–691. https://doi.org/10.1136/jnnp-2013-305972

Article  PubMed  Google Scholar 

Foulds P, McAuley E, Gibbons L, Davidson Y, Pickering-Brown SM, Neary D, Snowden JS, Allsop D et al (2008) TDP-43 protein in plasma may index TDP-43 brain pathology in Alzheimer’s disease and frontotemporal lobar degeneration. Acta Neuropathol 116(2):141–146. https://doi.org/10.1007/s00401-008-0389-8

Article  CAS  PubMed  PubMed Central  Google Scholar 

Foulds PG, Davidson Y, Mishra M, Hobson DJ, Humphreys KM, Taylor M, Johnson N, Weintraub S et al (2009) Plasma phosphorylated-TDP-43 protein levels correlate with brain pathology in frontotemporal lobar degeneration. Acta Neuropathol 118(5):647–658. https://doi.org/10.1007/s00401-009-0594-0

Article  CAS  PubMed  PubMed Central  Google Scholar 

Heller C, Foiani MS, Moore K, Convery R, Bocchetta M, Neason M, Cash DM, Thomas D et al (2020) Plasma glial fibrillary acidic protein is raised in progranulin-associated frontotemporal dementia. J Neurol Neurosurg Psychiatry 91(3):263–270. https://doi.org/10.1136/jnnp-2019-321954

Article  PubMed  Google Scholar 

Rojas JC, Wang P, Staffaroni AM, Heller C, Cobigo Y, Wolf A, Goh SM, Ljubenkov PA et al (2021) Plasma neurofilament light for prediction of disease progression in familial frontotemporal lobar degeneration. Neurology 96(18):e2296–e2312. https://doi.org/10.1212/wnl.0000000000011848

Article  CAS  PubMed  PubMed Central  Google Scholar 

Smith KR, Damiano J, Franceschetti S, Carpenter S, Canafoglia L, Morbin M, Rossi G, Pareyson D et al (2012) Strikingly different clinicopathological phenotypes determined by progranulin-mutation dosage. Am J Hum Genet 90(6):1102–1107. https://doi.org/10.1016/j.ajhg.2012.04.021

Article  CAS  PubMed  PubMed Central  Google Scholar 

Almeida M, Macario M, Ramos L, Baldeiras I, Ribeiro M, Santana I (2016) Portuguese family with the co-occurrence of frontotemporal lobar degeneration and neuronal ceroid lipofuscinosis phenotypes due to progranulin gene mutation. Neurobiol Aging 41(200):e201–e205. https://doi.org/10.1016/j.neurobiolaging.2016.02.019

Article  CAS  Google Scholar 

Huin V, Barbier M, Bottani A, Lobrinus JA, Clot F, Lamari F, Chat L, Rucheton B et al (2020) Homozygous GRN mutations: new phenotypes and new insights into pathological and molecular mechanisms. Brain 143(1):303–319. https://doi.org/10.1093/brain/awz377

Article  PubMed  Google Scholar 

Martens LH, Zhang J, Barmada SJ, Zhou P, Kamiya S, Sun B, Min SW, Gan L et al (2012) Progranulin deficiency promotes neuroinflammation and neuron loss following toxin-induced injury. J Clin Invest 122(11):3955–3959. https://doi.org/10.1172/JCI63113

Article  CAS  PubMed  PubMed Central  Google Scholar 

Petkau TL, Neal SJ, Milnerwood A, Mew A, Hill AM, Orban P, Gregg J, Lu G et al (2012) Synaptic dysfunction in progranulin-deficient mice. Neurobiol Dis 45(2):711–722. https://doi.org/10.1016/j.nbd.2011.10.016

Article  CAS  PubMed  Google Scholar 

Yin F, Banerjee R, Thomas B, Zhou P, Qian L, Jia T, Ma X, Ma Y et al (2010) Exaggerated inflammation, impaired host defense, and neuropathology in progranulin-deficient mice. J Exp Med 207(1):117–128. https://doi.org/10.1084/jem.20091568

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kayasuga Y, Chiba S, Suzuki M, Kikusui T, Matsuwaki T, Yamanouchi K, Kotaki H, Horai R et al (2007) Alteration of behavioural phenotype in mice by targeted disruption of the progranulin gene. Behav Brain Res 185(2):110–118. https://doi.org/10.1016/j.bbr.2007.07.020

Article  CAS  PubMed  Google Scholar 

Fujita K, Chen X, Homma H, Tagawa K, Amano M, Saito A, Imoto S, Akatsu H et al (2018) Targeting Tyro3 ameliorates a model of PGRN-mutant FTLD-TDP via tau-mediated synaptic pathology. Nat Commun 9(1):433. https://doi.org/10.1038/s41467-018-02821-z

Article  CAS  PubMed  PubMed Central  Google Scholar 

Nguyen AD, Nguyen TA, Zhang J, Devireddy S, Zhou P, Xu X, Karydas AM, Miller BL, Rigo F et al (2018) Murine knockin model for progranulin-deficient frontotemporal dementia with nonsense-mediated mRNA decay. Proc Natl Acad Sci USA 115(12):E2849–E2858

Article  CAS  PubMed  PubMed Central  Google Scholar 

Tanaka Y, Chambers JK, Matsuwaki T, Yamanouchi K, Nishihara M (2014) Possible involvement of lysosomal dysfunction in pathological changes of the brain in aged progranulin-deficient mice. Acta Neuropathol Commun 2:78

Article  PubMed  PubMed Central  Google Scholar 

Götzl JK, Mori K, Damme M, Fellerer K, Tahirovic S, Kleinberger G, Janssens J, van der Zee J et al (2014) Common pathobiochemical hallmarks of progranulin-associated frontotemporal lobar degeneration and neuronal ceroid lipofuscinosis. Acta Neuropathol 127(6):845–860. https://doi.org/10.1007/s00401-014-1262-6

Article  CAS  PubMed  Google Scholar 

Chang MC, Srinivasan K, Friedman BA, Suto E, Modrusan Z, Lee WP, Kaminker JS, Hansen DV et al (2017) Progranulin deficiency causes impairment of autophagy and TDP-43 accumulation. J Exp Med 214(9):2611–2628. https://doi.org/10.1084/jem.20160999